Locations:
Treating a challenging cancer with novel use of radioembolization and SBRT
Number of brain metastases doesn’t matter for ALK/EGFR+ patients
Cleveland Clinic-led study lays groundwork for more personalized treatments
May extend disease-free and overall survival with good quality of life
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Luspatercept shows promise for patients with few options
Even when cancer clinical trials are available, fewer eAYAs than children enroll
Searching for new insights into drug resistance, collateral sensitivity
20 years of data suggest that ablation is a valid treatment option
Knocking out, then restoring, the immune system holds great promise
Molecular study suggests an update to AJCC guidelines
Advertisement
Advertisement
Search